LATISSE^® solution is a prescription treatment for hypotrichosis used to grow eyelashes, making them longer, thicker and darker. Eyelash hypotrichosis is another name for having inadequate or not enough eyelashes. It is a once-a-day treatment you apply topically to the base of your upper eyelashes. Patients in a clinical trial saw results in as few as 8 weeks with full results after 12-16 weeks.

LATISSE was introduced in the first quarter of 2009 by Allergan as the first drug to receive FDA approval for eyelash growth. LATISSE is a solution of bimatoprost, the active component of the glaucoma medication LUMIGAN^®. Growth is reported to occur primarily on the upper eyelashes. In addition, the past decade has seen the rapid increase in the development of eyelash conditioners. These conditioners are designed to increase the health and length of lashes. Many utilize seed extract, minerals, and other chemicals to achieve these results.

Its cosmetic capabilities are an unintended and unforeseen side effect. When LATISSE is applied once daily to the skin at the base of the user’s eyelashes, it activates certain hormone receptors in the hair follicle, which stimulates hair growth.